Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Berger

Showing results (111-120 of 277) with videos related to

Pageof 28
Sort By:
The Journal of Pediatrics: X|June 19, 2023
A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 YearsDunbar Ivy, Maurice Beghetti, Ernesto Juaneda-Simian, et al.
Scientific Reports|November 28, 2022
Opportunities and short-comings of the axolotl salamander heart as a model system of human single ventricle and excessive trabeculationSophie Meyer, Henrik Lauridsen, Kathrine Pedersen, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2017
Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial HypertensionLynn J Leberkühne, Mark-Jan Ploegstra, Johannes M Douwes, et al.
International Journal of Cardiology|September 21, 2015
Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertensionJohannes M Douwes, Anneke K Hegeman, Merel B van der Krieke, et al.
Children (Basel, Switzerland)|May 16, 2023
Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial HypertensionMeindina G Haarman, Iris Coenraad, Quint A J Hagdorn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2016
Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertensionDiederik E van der Feen, Michael G Dickinson, Beatrijs Bartelds, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 1, 2014
Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterloadMarinus A Borgdorff, Beatrijs Bartelds, Michael G Dickinson, et al.
Cardiology in the Young|June 10, 2020
N-terminal pro-brain natriuretic peptide serum levels reflect attrition of the Fontan circulationDjoeke Wolff, Joost P van Melle, Tineke P Willems, et al.
The Journal of Pediatrics|March 9, 2026
Macitentan vs Standard of Care in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical TrialRolf M F Berger, D Dunbar Ivy, Julian I Borissoff, et al.
Paediatric and Perinatal Epidemiology|January 18, 2018
Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: A systematic review and meta-analysisSanne Arjaans, Elvira A H Zwart, Mark-Jan Ploegstra, et al.
Pageof 28

Showing results (111-120 of 277) with videos related to

Sort By:
Pageof 28
The Journal of Pediatrics: X|June 19, 2023
A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 YearsDunbar Ivy, Maurice Beghetti, Ernesto Juaneda-Simian, et al.
Scientific Reports|November 28, 2022
Opportunities and short-comings of the axolotl salamander heart as a model system of human single ventricle and excessive trabeculationSophie Meyer, Henrik Lauridsen, Kathrine Pedersen, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2017
Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial HypertensionLynn J Leberkühne, Mark-Jan Ploegstra, Johannes M Douwes, et al.
International Journal of Cardiology|September 21, 2015
Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertensionJohannes M Douwes, Anneke K Hegeman, Merel B van der Krieke, et al.
Children (Basel, Switzerland)|May 16, 2023
Cardiac Magnetic Resonance Derived Left Ventricular Eccentricity Index and Right Ventricular Mass Measurements Predict Outcome in Children with Pulmonary Arterial HypertensionMeindina G Haarman, Iris Coenraad, Quint A J Hagdorn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 18, 2016
Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertensionDiederik E van der Feen, Michael G Dickinson, Beatrijs Bartelds, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 1, 2014
Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterloadMarinus A Borgdorff, Beatrijs Bartelds, Michael G Dickinson, et al.
Cardiology in the Young|June 10, 2020
N-terminal pro-brain natriuretic peptide serum levels reflect attrition of the Fontan circulationDjoeke Wolff, Joost P van Melle, Tineke P Willems, et al.
The Journal of Pediatrics|March 9, 2026
Macitentan vs Standard of Care in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical TrialRolf M F Berger, D Dunbar Ivy, Julian I Borissoff, et al.
Paediatric and Perinatal Epidemiology|January 18, 2018
Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: A systematic review and meta-analysisSanne Arjaans, Elvira A H Zwart, Mark-Jan Ploegstra, et al.
Pageof 28